These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

188 related items for PubMed ID: 15199444

  • 21. Long-term prognostic significance of high-sensitivity C-reactive protein before and after coronary angioplasty in patients with stable angina pectoris.
    Gach O, Legrand V, Biessaux Y, Chapelle JP, Vanbelle S, Pierard LA.
    Am J Cardiol; 2007 Jan 01; 99(1):31-5. PubMed ID: 17196457
    [Abstract] [Full Text] [Related]

  • 22. Incremental value of high-sensitivity C-reactive protein and N-terminal pro-B-type natriuretic peptide for the prediction of postoperative cardiac events in noncardiac vascular surgery patients.
    Goei D, Hoeks SE, Boersma E, Winkel TA, Dunkelgrun M, Flu WJ, Schouten O, Bax JJ, Poldermans D.
    Coron Artery Dis; 2009 May 01; 20(3):219-24. PubMed ID: 19322079
    [Abstract] [Full Text] [Related]

  • 23. [Redefinition of myocardial infarction--relevance of biomarkers].
    Weber M, Hamm C.
    Herz; 2008 Mar 01; 33(2):115-21. PubMed ID: 18344030
    [Abstract] [Full Text] [Related]

  • 24. A multi-marker approach for the prediction of adverse events in patients with acute coronary syndromes.
    Cameron SJ, Sokoll LJ, Laterza OF, Shah S, Green GB.
    Clin Chim Acta; 2007 Feb 01; 376(1-2):168-73. PubMed ID: 17011538
    [Abstract] [Full Text] [Related]

  • 25. Usefulness of elevations in serum choline and free F2)-isoprostane to predict 30-day cardiovascular outcomes in patients with acute coronary syndrome.
    LeLeiko RM, Vaccari CS, Sola S, Merchant N, Nagamia SH, Thoenes M, Khan BV.
    Am J Cardiol; 2009 Sep 01; 104(5):638-43. PubMed ID: 19699337
    [Abstract] [Full Text] [Related]

  • 26. C-reactive protein increase in unstable coronary disease cause or effect?
    De Servi S, Mariani M, Mariani G, Mazzone A.
    J Am Coll Cardiol; 2005 Oct 18; 46(8):1496-502. PubMed ID: 16226174
    [Abstract] [Full Text] [Related]

  • 27. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B, von Scheidt W, Kling B, Heier M, Hoermann A, Meisinger C.
    Am J Cardiol; 2008 Nov 01; 102(9):1125-30. PubMed ID: 18940277
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Admission C-reactive protein serum levels and survival in patients with acute myocardial infarction with persistent ST elevation.
    Canale ML, Stroppa S, Caravelli P, Petronio AS, Mariotti R, Mariani M, Balbarini A, Barsotti A.
    Coron Artery Dis; 2006 Dec 01; 17(8):693-8. PubMed ID: 17119378
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. C-reactive protein, prothrombotic imbalance and endothelial dysfunction in acute coronary syndromes without ST elevation.
    Apetrei E, Ciobanu-Jurcuţ R, Rugină M, Gavrilă A, Uscătescu V.
    Rom J Intern Med; 2004 Dec 01; 42(1):95-102. PubMed ID: 15529598
    [Abstract] [Full Text] [Related]

  • 33. Prognostic significance of interleukin-6 measurement in the diagnosis of acute myocardial infarction in emergency department.
    Ferroni P, Rosa A, Di Franco M, Palmirotta R, Guadagni F, Davì G, Bertazzoni G, Basili S.
    Clin Chim Acta; 2007 Jun 01; 381(2):151-6. PubMed ID: 17408606
    [Abstract] [Full Text] [Related]

  • 34. Redefining risk in acute coronary syndromes using molecular medicine.
    Anwaruddin S, Askari AT, Topol EJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):279-89. PubMed ID: 17239708
    [Abstract] [Full Text] [Related]

  • 35. Soluble CXCL16 predicts long-term mortality in acute coronary syndromes.
    Jansson AM, Aukrust P, Ueland T, Smith C, Omland T, Hartford M, Caidahl K.
    Circulation; 2009 Jun 30; 119(25):3181-8. PubMed ID: 19528340
    [Abstract] [Full Text] [Related]

  • 36. Troponins in acute coronary syndromes.
    Scirica BM, Morrow DA.
    Semin Vasc Med; 2003 Nov 30; 3(4):363-74. PubMed ID: 15199443
    [Abstract] [Full Text] [Related]

  • 37. [Guidelines: acute coronary syndrome (ACS). 1: ACS without persistent ST segment elevations].
    Hamm CW, Deutsche Gesellschaft fur Kardiologie- Herz- und Kreislaufforschung.
    Z Kardiol; 2004 Jan 30; 93(1):72-90. PubMed ID: 14740245
    [No Abstract] [Full Text] [Related]

  • 38. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.
    Am J Kidney Dis; 2009 Jun 30; 53(6):1024-33. PubMed ID: 19394732
    [Abstract] [Full Text] [Related]

  • 39. [C-reactive protein and relative lymphocytopenia: early markers of acute myocardial infarction?].
    Annen B, Mang G, Schuiki E, Strebel U, Knoblauch M.
    Schweiz Med Wochenschr; 1999 Dec 11; 129(49):1931-4. PubMed ID: 10635086
    [Abstract] [Full Text] [Related]

  • 40. Clinical significance of macrophage colony stimulating factor levels in acute coronary syndrome.
    Novo G, Assennato P, Caruso M, Turturici C, Balistreri CR, Amoroso GR, Fazio G, Rotolo A, Coppola G, Hoffmann E, Caruso C, Novo S.
    Minerva Cardioangiol; 2009 Feb 11; 57(1):7-11. PubMed ID: 19202515
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.